The city of Norman, Oklahoma, currently has 2 active clinical trials seeking participants for Ulcerative Colitis research studies.
A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of RO7790121 compared with placebo in participants with moderately to severely active ulcerative colitis (UC).
Gender:
ALL
Ages:
Between 16 years and 80 years
Trial Updated:
02/01/2025
Locations: Central Sooner Research, Norman, Oklahoma
Conditions: Moderately to Severely Active Ulcerative Colitis
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Recruiting
ROSETTA STUDY: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe ulcerative colitis (UC)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/27/2024
Locations: AnaptysBio Investigative Site 10-120, Norman, Oklahoma
Conditions: Ulcerative Colitis